G70.01
Myasthenia gravis with (acute) exacerbation
Clinical Classification Guidelines
Inclusion Terms
- Myasthenia gravis in crisis
Medical Intelligence & Overview
Myasthenia gravis with acute exacerbation, also known as myasthenic crisis, is a serious condition where the symptoms of myasthenia gravis suddenly worsen. This can lead to significant muscle weakness, especially affecting the muscles that control breathing. Recognizing and understanding this condition is crucial for timely medical intervention and management to prevent life-threatening complications.
Causes & Symptoms
Clinical Causes: Infections, such as respiratory or urinary tract infections, that can stimulate an immune response Stress, including physical or emotional stress that may trigger symptom worsening Medication changes or missed doses of myasthenia gravis treatments Hormonal fluctuations, especially in women during pregnancy or around menstrual cycles Surgery or anesthesia, which can temporarily weaken muscle strength Other illnesses or illnesses that can exacerbate immune response
Key Symptoms: Sudden muscle weakness that worsens over a few hours or days Difficulty swallowing or speaking Severe fatigue and muscle exhaustion Shortness of breath or breathing difficulty Drooping eyelids (ptosis) Difficulty with eye movements, double vision (diplopia) Weakness in neck or limb muscles
Diagnostic & Treatment
Diagnosis Path: Physical and neurological examinations to assess muscle strength and reflexes Blood tests to detect antibodies associated with myasthenia gravis Electromyography (EMG) to evaluate electrical activity in muscles Imaging studies such as CT or MRI scans of the chest to look for thymoma (a tumor of the thymus gland) Edrophonium test, which measures response to a specific medication that temporarily improves muscle strength Pulmonary function tests to assess breathing capacity, especially important during an exacerbation
Treatment Protocols: Hospitalization for close monitoring and support, especially if breathing is affected Medications such as acetylcholinesterase inhibitors (e.g., pyridostigmine) to improve communication between nerves and muscles Immunosuppressants to reduce immune system activity that attacks the neuromuscular junction Plasmapheresis and intravenous immunoglobulin (IVIG) to remove or block harmful antibodies Supportive therapies including respiratory support like oxygen therapy or mechanical ventilation if necessary Addressing underlying causes, such as infections, with appropriate antibiotics or antiviral medications Adjustment or optimization of long-term treatment plans to prevent future crises
Clinical Advice & FAQs
Billing Guidance
Is G70.01 a billable ICD-10 code?
Yes, G70.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G70.01?
Clinical documentation must specify the nature of Myasthenia gravis with (acute) exacerbation and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
